Opportunity Information: Apply for PAR 18 437
The Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional) funding opportunity, offered by the National Institute on Drug Abuse (NIDA) within the National Institutes of Health (NIH), is aimed at supporting bold, unconventional basic research on substance use disorders (SUDs). The program is intentionally geared toward ideas that are early, risky, and potentially transformative, especially work that does not fit neatly into NIDA's existing research portfolio or is currently underrepresented within it. In practical terms, CEBRA is meant to push the field forward by backing projects that could reshape how scientists think about addiction, even if there is little prior work or limited preliminary data available to support the concept at the time of application.
The scientific scope is broad across core addiction research areas, including the etiology and causes of SUDs, the underlying biology and pathophysiology, and approaches relevant to prevention or treatment. What matters most is the degree of innovation and the likelihood that the work could have high impact. The solicitation highlights two main types of projects it wants to encourage. First are studies that test a significant, novel hypothesis where existing precedent is scant, but where confirmation would substantially change current understanding of addiction or related mechanisms. Second are projects that develop, adapt, or apply revolutionary tools, techniques, or methods for addiction research, including approaches that may not yet be widely used in SUD science but have strong promise for future applicability. Because it uses the NIH R21 mechanism, the emphasis is on exploratory, early-stage research rather than fully matured programs with extensive supporting data, which makes it a particularly good fit for high-concept pilot directions or method-building efforts.
Administratively, this is a discretionary grant opportunity (funding instrument: grant) under the activity areas of education and health, with CFDA number 93.279. The opportunity number is PAR 18 437, and the program was created on 2018-01-09. The listing notes an original closing date of 2021-02-10, which is important because applicants should treat that date as historically specific and verify whether the announcement has been reissued, extended, or replaced by a newer version before planning a submission.
The award information provided includes an award ceiling of $150,000. The expected number of awards is not specified in the provided data, which often means the institute will make awards based on available appropriations and the merit of applications received rather than committing to a fixed count.
Eligibility is broad and includes many common applicant types across government, higher education, nonprofit, and private sectors. Eligible applicants explicitly include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other entities. The announcement also emphasizes inclusion of additional applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-domestic (non-U.S.) entities (foreign organizations). This wide eligibility reflects NIDA's interest in pulling in innovative ideas from many types of institutions and communities, including those that may bring different perspectives, methods, or population-relevant insights to addiction research.
Finally, the "clinical trial optional" designation signals that an application may include a clinical trial if it is appropriate for the proposed aims, but a clinical trial is not required. For many applicants, that means the program can support both lab-based or preclinical basic research and certain human-focused studies, as long as the work is consistent with the award's core purpose: testing a novel, potentially paradigm-shifting hypothesis or creating/advancing breakthrough methods that could meaningfully accelerate SUD research.Apply for PAR 18 437
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2018-01-09.
- Applicants must submit their applications by 2021-02-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)
Previous opportunity: NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 437
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 437) also looked into and applied for these:
| Funding Opportunity |
|---|
| International Research Collaboration on Drug Abuse and Addiction Research (R01, Clinical Trial Optional) Apply for PA 18 568 Funding Number: PA 18 568 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01, Clinical Trial Optional) Apply for PA 18 569 Funding Number: PA 18 569 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01 Clinical Trial Optional) Apply for PA 18 603 Funding Number: PA 18 603 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Apply for PAR 18 605 Funding Number: PAR 18 605 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03 Clinical Trial Optional) Apply for PA 18 601 Funding Number: PA 18 601 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21 Clinical Trial Optional) Apply for PA 18 602 Funding Number: PA 18 602 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Apply for PAR 18 606 Funding Number: PAR 18 606 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Training Modules to Enhance the Rigor and Reproducibility of Biomedical Research (R25 Clinical Trial Not Allowed) Apply for RFA GM 18 002 Funding Number: RFA GM 18 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 Clinical Trial Optional) Apply for PAR 18 612 Funding Number: PAR 18 612 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 Clinical Trial Optional) Apply for PAR 18 611 Funding Number: PAR 18 611 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional) Apply for PAS 18 624 Funding Number: PAS 18 624 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional) Apply for PAS 18 625 Funding Number: PAS 18 625 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| NIDA Small Research Grant Program (R03 Clinical Trial Required) Apply for PA 18 626 Funding Number: PA 18 626 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| NIDA Academic Research Enhancement Award (R15, Clinical Trials Required) Apply for PA 18 627 Funding Number: PA 18 627 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Apply for PA 18 629 Funding Number: PA 18 629 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,999 |
| NIDA Small Research Grant Program (R03 Clinical Trial Required) Apply for PA 18 634 Funding Number: PA 18 634 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional) Apply for PAR 18 638 Funding Number: PAR 18 638 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) Apply for PAR 18 641 Funding Number: PAR 18 641 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Apply for PAR 18 640 Funding Number: PAR 18 640 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed) Apply for RFA MD 18 006 Funding Number: RFA MD 18 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 437", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
